These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29885559)

  • 1.
    Rezazadeh F; Sadeghzadeh N; Abedi SM; Abediankenari S
    Nucl Med Biol; 2018; 62-63():54-62. PubMed ID: 29885559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of
    Maleki F; Masteri Farahani A; Sadeghzadeh N; Mardanshahi A; Abediankenari S
    Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
    Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
    Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
    Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
    Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
    Emrarian I; Sadeghzadeh N; Abedi SM; Abediankenari S
    Chem Biol Drug Des; 2018 Jan; 91(1):304-313. PubMed ID: 28816013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical translation of a PSMA inhibitor for
    Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricine co-ligand improved the efficacy of
    Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
    Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro/in vivo assessment of the targeting ability of [
    Ranjbar L; Maleki F; Sadeghzadeh N; Abediankenari S; Mardanshahi A; Masteri Farahani A
    Ann Nucl Med; 2020 Jul; 34(7):460-466. PubMed ID: 32390105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.
    Liu Z; Liu H; Ma T; Sun X; Shi J; Jia B; Sun Y; Zhan J; Zhang H; Zhu Z; Wang F
    J Nucl Med; 2014 Jun; 55(6):989-94. PubMed ID: 24711651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved
    Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
    Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ; Yu Z; Dierckx RA; van der Wiele C; Helfrich W; Wang F; Yan Y; Chen X; de Jong IJ; Elsinga PH
    Mol Pharm; 2011 Aug; 8(4):1165-73. PubMed ID: 21699202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.